Lucid: Brace For Turmoil

Summary:

  • Investors need to brace for a bumpy ride as Lucid’s FY23 production guidance falls woefully short, signaling the need for significant cuts in forward estimates.
  • As macro headwinds remain uncertain and Tesla slashes prices, the company’s premium price point is a significant headwind.
  • Lucid’s future is at stake as they could face a liquidity crunch by early 2024, leaving them high and dry without additional funding from the PIF or other stakeholders.
  • Lucid’s profitability path could be further delayed as its production ramp cadence faces significant disruption.

Las Vegas Hosts Annual CES Trade Show

David Becker

Lucid Group, Inc. (NASDAQ:LCID) delivered a disappointing report for its recent FQ4’22 earnings release, posting revenue and adjusted EBITDA below the consensus estimates.

However, the stunner came from its outlook for FY23, as CEO Peter Rawlinson and his team proffered

LCID price chart (weekly)

LCID price chart (weekly) (TradingView)


Disclosure: I/we have a beneficial long position in the shares of TSLA either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.


Are you looking to strategically enter the market and optimize gains?

Unlock the key to successful growth stock investments with our expert guidance on identifying lower-risk entry points and capitalizing on them for long-term profits. As a member, you’ll also gain access to exclusive resources including:

  • 24/7 access to our model portfolios

  • Daily Tactical Market Analysis to sharpen your market awareness and avoid the emotional rollercoaster

  • Access to all our top stocks and earnings ideas

  • Access to all our charts with specific entry points

  • Real-time chatroom support

  • Real-time buy/sell/hedge alerts

Sign up now for a Risk-Free 14-Day free trial!

Leave a Reply

Your email address will not be published. Required fields are marked *